Unlocking capacities of viral genomics for the COVID-19 pandemic response
Authors:
Sergey Knyazev,
Karishma Chhugani,
Varuni Sarwal,
Ram Ayyala,
Harman Singh,
Smruthi Karthikeyan,
Dhrithi Deshpande,
Zoia Comarova,
Angela Lu,
Yuri Porozov,
Aiping Wu,
Malak Abedalthagafi,
Shivashankar Nagaraj,
Adam Smith,
Pavel Skums,
Jason Ladner,
Tommy Tsan-Yuk Lam,
Nicholas Wu,
Alex Zelikovsky,
Rob Knight,
Keith Crandall,
Serghei Mangul
Abstract:
More than any other infectious disease epidemic, the COVID-19 pandemic has been characterized by the generation of large volumes of viral genomic data at an incredible pace due to recent advances in high-throughput sequencing technologies, the rapid global spread of SARS-CoV-2, and its persistent threat to public health. However, distinguishing the most epidemiologically relevant information encod…
▽ More
More than any other infectious disease epidemic, the COVID-19 pandemic has been characterized by the generation of large volumes of viral genomic data at an incredible pace due to recent advances in high-throughput sequencing technologies, the rapid global spread of SARS-CoV-2, and its persistent threat to public health. However, distinguishing the most epidemiologically relevant information encoded in these vast amounts of data requires substantial effort across the research and public health communities. Studies of SARS-CoV-2 genomes have been critical in tracking the spread of variants and understanding its epidemic dynamics, and may prove crucial for controlling future epidemics and alleviating significant public health burdens. Together, genomic data and bioinformatics methods enable broad-scale investigations of the spread of SARS-CoV-2 at the local, national, and global scales and allow researchers the ability to efficiently track the emergence of novel variants, reconstruct epidemic dynamics, and provide important insights into drug and vaccine development and disease control. Here, we discuss the tremendous opportunities that genomics offers to unlock the effective use of SARS-CoV-2 genomic data for efficient public health surveillance and guiding timely responses to COVID-19.
△ Less
Submitted 4 June, 2021; v1 submitted 28 April, 2021;
originally announced April 2021.
RNA-seq data science: From raw data to effective interpretation
Authors:
Dhrithi Deshpande,
Karishma Chhugani,
Yutong Chang,
Aaron Karlsberg,
Caitlin Loeffler,
Jinyang Zhang,
Agata Muszynska,
Jeremy Rotman,
Laura Tao,
Brunilda Balliu,
Elizabeth Tseng,
Eleazar Eskin,
Fangqing Zhao,
Pejman Mohammadi,
Pawel P Labaj,
Serghei Mangul
Abstract:
RNA-sequencing (RNA-seq) has become an exemplar technology in modern biology and clinical applications over the past decade. It has gained immense popularity in the recent years driven by continuous efforts of the bioinformatics community to develop accurate and scalable computational tools. RNA-seq is a method of analyzing the RNA content of a sample using the modern sequencing platforms. It gene…
▽ More
RNA-sequencing (RNA-seq) has become an exemplar technology in modern biology and clinical applications over the past decade. It has gained immense popularity in the recent years driven by continuous efforts of the bioinformatics community to develop accurate and scalable computational tools. RNA-seq is a method of analyzing the RNA content of a sample using the modern sequencing platforms. It generates enormous amounts of transcriptomic data in the form of nucleotide sequences, known as reads. RNA-seq analysis enables the probing of genes and corresponding transcripts which is essential for answering important biological questions, such as detecting novel exons, transcripts, gene expressions, and studying alternative splicing structure. However, obtaining meaningful biological signals from raw data using computational methods is challenging due to the limitations of modern sequencing technologies. The need to leverage these technological challenges have pushed the rapid development of many novel computational tools which have evolved and diversified in accordance with technological advancements, leading to the current myriad population of RNA-seq tools. Our review provides a systemic overview of RNA-seq technology and 235 available RNA-seq tools across various domains published from 2008 to 2020, discussing the interdisciplinary nature of bioinformatics involved in RNA sequencing, analysis, and software development.
△ Less
Submitted 16 February, 2021; v1 submitted 5 October, 2020;
originally announced October 2020.
